Recent advances in understanding the molecular basis of infantile haemangioma development
British Journal of Dermatology · 17.10.2024 · 191 (5) · 661-669
DOI: 10.1093/bjd/ljae241 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift British Journal of Dermatology, online erschienen am 07.06.2024. Verfasst von Raka Mitra und 5 weiteren Autor:innen. Beteiligte Einrichtung: Gillies McIndoe Research Institute, Newtown, Wellington, New Zealand. Hauptthemen laut MEDLINE: Neovascularization, Pathologic, Hemangioma. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Infantile haemangioma (IH) – the most common vascular tumour of infancy – is comprised of diverse cell types, including endothelial cells, pericytes, fibroblasts and immune cells. IH is characterized by rapid proliferation followed by slow involution over 1–10 years. Most lesions regress spontaneously, but up to 10% can be disfiguring, with complications that require further medical treatment. Recent research has revealed the biological characteristics of IH, highlighting the involvement of angiogenesis and vasculogenesis during tumour formation. Gene expression profiling has provided vital insights into the underlying biological processes, with some of the key IH-related pathways identified, including vascular endothelial growth factor, the renin–angiotensin–aldosterone system, hypoxia-inducible factor 1α, Notch, platelet-derived growth factor, phosphoinositide 3-kinase/Akt/mammalian target of rapamycin, Janus kinase/signal transducers and activators of transcription, fibroblast growth factor, peroxisome proliferator-activated receptor-γ and insulin-like growth factor. Further evidence suggests extracellular matrix factors and hormone receptors regulate IH progression. In this review, we explore the molecular mechanisms involved in the proliferating, plateau and involuting phases of IH, identifying differentially expressed genes, targeted proteins and key signalling pathways. This knowledge will increase the broader understanding of vascular development, tissue remodelling and angiogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Gillies McIndoe Research Institute, Newtown, Wellington, New Zealand.
- School of Food Technology and Natural Sciences, Massey University, Palmerston North, New Zealand.
- Wellington Regional Plastic, Maxillofacial and Burns Unit, Hutt Hospital, Lower Hutt, New Zealand.
- Department of Surgery, The Royal Melbourne Hospital, The University of Melbourne, Melbourne, VIC, Australia.
- Centre for Biodiscovery and School of Biological Sciences, Victoria University of Wellington, Kelburn, Wellington, New Zealand.
ORCID-Profile: Madeleine P J White
Zitieren
APA
Mitra, R., Fitzsimons, H. L., Hale, T., Tan, S. T., Gray, C., & White, M. P. J. (2024). Recent advances in understanding the molecular basis of infantile haemangioma development. British Journal of Dermatology, 191(5), 661-669. https://doi.org/10.1093/bjd/ljae241
Vancouver
Mitra R, Fitzsimons HL, Hale T, Tan ST, Gray C, White MPJ. Recent advances in understanding the molecular basis of infantile haemangioma development. British Journal of Dermatology. 2024;191(5):661-669. doi:10.1093/bjd/ljae241
BibTeX
@article{Mitra2024,
author = {Mitra, Raka and Fitzsimons, Helen L and Hale, Tracy and Tan, Swee T and Gray, Clint and White, Madeleine P J},
title = {Recent advances in understanding the molecular basis of infantile haemangioma development},
journal = {British Journal of Dermatology},
year = {2024},
volume = {191},
number = {5},
pages = {661--669},
doi = {10.1093/bjd/ljae241}
}
EUVIMED